Chemistry:Acenocoumarol
From HandWiki
Short description: Anticoagulant
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Elimination half-life | 8 to 11 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H15NO6 |
| Molar mass | 353.330 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| Melting point | 196 to 199 °C (385 to 390 °F) |
| |
| |
| (verify) | |
Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist (like warfarin). It is a derivative of coumarin and is generic, so is marketed under many brand names worldwide.[1]
References
Further reading
- "Aging and oral anticoagulant therapy using acenocoumarol". Blood Coagulation & Fibrinolysis 15 (8): 673–676. October 2004. doi:10.1097/00001721-200412000-00007. PMID 15613922.
- "[Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation?]". Orvosi Hetilap 145 (52): 2619–2621. December 2004. PMID 15724697.
- "Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol". Clinical Pharmacokinetics 44 (12): 1227–1246. 2005. doi:10.2165/00003088-200544120-00003. PMID 16372822.
- "The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients". British Journal of Haematology 133 (2): 183–187. April 2006. doi:10.1111/j.1365-2141.2006.06007.x. PMID 16611310.
External links

